Scientists check if common pill alters cancer drug
NCT ID NCT02157883
Summary
This study aimed to understand how a common antifungal drug (itraconazole) affects the blood levels of a lung cancer drug (AZD9291, now known as osimertinib). It involved 39 adults with a specific type of advanced lung cancer that had worsened after previous treatment. The main goal was to measure drug interactions, not to test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
San Diego, California, 92123, United States
-
Research Site
Cleveland, Ohio, 44106, United States
-
Research Site
Edegem, 2650, Belgium
-
Research Site
Ghent, 9000, Belgium
-
Research Site
Amsterdam, 1066 CX, Netherlands
-
Research Site
Maastricht, 6229 HX, Netherlands
-
Research Site
Rotterdam, 3015 GD, Netherlands
-
Research Site
lJongno-gu, 03080, South Korea
-
Research Site
Seongnam-si, 13620, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 05505, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Taipei, 10002, Taiwan
-
Research Site
Taipei, 11217, Taiwan
-
Research Site
London, SE1 9RT, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
Conditions
Explore the condition pages connected to this study.